May 8, 2017 / 3:06 AM / in 5 months

BRIEF-Jiangxi Fushine Pharmaceutical receives GMP certificate

May 8 (Reuters) - Jiangxi Fushine Pharmaceutical Co Ltd :

* Says it received goods manufacture practice (GMP) certificate from Jiangxi Food and Drug Administration

* Certificate issued tazobactam and sultamicillin tosilate manufactured by the company and the valid period is until May 1. 2022

Source text in Chinese: goo.gl/qcwllV

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below